Header Logo

Connection

Cynthia Firnhaber to Papillomavirus Infections

This is a "connection" page, showing publications Cynthia Firnhaber has written about Papillomavirus Infections.
Connection Strength

4,293
  1. Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial. Clin Infect Dis. 2021 10 05; 73(7):e2211-e2216.
    View in: PubMed
    Score: 0,715
  2. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer. Cancer Cytopathol. 2016 10; 124(10):695-698.
    View in: PubMed
    Score: 0,492
  3. Human papillomavirus vaccines: where do they fit in HIV-infected individuals? Curr HIV/AIDS Rep. 2012 Sep; 9(3):278-86.
    View in: PubMed
    Score: 0,381
  4. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana. J Clin Virol. 2011 Nov; 52(3):265-8.
    View in: PubMed
    Score: 0,356
  5. Human papillomavirus types in HIV seropositive men with penile warts in Johannesburg, South Africa. Int J STD AIDS. 2011 Feb; 22(2):107-9.
    View in: PubMed
    Score: 0,341
  6. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control. 2010 Mar; 21(3):433-43.
    View in: PubMed
    Score: 0,315
  7. Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa. Acta Cytol. 2009 Jan-Feb; 53(1):10-7.
    View in: PubMed
    Score: 0,295
  8. Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infection. AIDS Res Ther. 2024 Dec 30; 21(1):101.
    View in: PubMed
    Score: 0,224
  9. A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers. Cancer Prev Res (Phila). 2020 10; 13(10):829-840.
    View in: PubMed
    Score: 0,164
  10. Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women. Carcinogenesis. 2019 04 29; 40(2):225-233.
    View in: PubMed
    Score: 0,151
  11. Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1. Papillomavirus Res. 2018 12; 6:15-21.
    View in: PubMed
    Score: 0,144
  12. Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected Women. Am J Clin Pathol. 2017 Aug 01; 148(2):148-153.
    View in: PubMed
    Score: 0,134
  13. Prevalence of Anal HPV and Anal Dysplasia in HIV-Infected Women From Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2017 07 01; 75(3):e59-e64.
    View in: PubMed
    Score: 0,133
  14. Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa. PLoS One. 2016; 11(1):e0144905.
    View in: PubMed
    Score: 0,120
  15. Anal dysplasia in HIV-infected women: a commentary on the field. Int J STD AIDS. 2017 May; 28(6):543-549.
    View in: PubMed
    Score: 0,119
  16. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. Clin Infect Dis. 2014 Jul 01; 59(1):127-35.
    View in: PubMed
    Score: 0,106
  17. Improving diagnostic capability for HPV disease internationally within the NIH-NIAID Division of AIDS Clinical Trial Networks. Am J Clin Pathol. 2013 Dec; 140(6):881-9.
    View in: PubMed
    Score: 0,104
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.